A Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions
Status: Active_not_recruiting
Location: See all (62) locations...
Study Type: Observational
SUMMARY
TARGET-DERM is a longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• 1\. Adults and children (all ages) with Atopic Dermatitis or other Immune-mediated Inflammatory Skin Conditions been prescribed any dermatologic treatment.
• 2\. Participant has plans for future visits at the site for continued management of IMISC.
Locations
United States
Arkansas
Johnson Dermatology
Fort Smith
Arkansas Dermatology
Little Rock
University of Arkansas for Medical Sciences
Little Rock
Arizona
Clear Dermatology & Aesthetics Center/Investigative MD
Scottsdale
California
First OC Dermatology
Fountain Valley
Center for Dermatology Cosmetic and Laser Surgery
Fremont
University of California
Irvine
University of California - San Diego/Rady Children's Hospital
San Diego
Washington, D.c.
George Washington University
Washington D.c.
Florida
Feinstein Dermatology and Cosmetic Surgery
Hollywood
Academic Alliance in Dermatology
Tampa
Integrated Dermatology of West Palm Beach
West Palm Beach
Illinois
Lurie Children's Hospital/Northwestern University
Chicago
Indiana
Dawes Fretzin Dermatology/ Dawes Fretzin Clinical Research Group
Indianapolis
Kansas
The University of Kansas Medical Center
Kansas City
Kentucky
Family Allergy and Asthma Research Institute
Louisville
Massachusetts
Integrated Dermatology of Massachusetts
Quincy
University of Massachusetts Medical School
Worcester
Maryland
DermAssociates, LCC
Rockville
Minnesota
University of Minnesota
Minneapolis
Mayo Clinic
Rochester
Montana
Carl Thornblade, MD, PLLC
Missoula
North Carolina
Allergy Partners of Western North Carolina
Asheville
UNC Dermatology
Chapel Hill
Wake Forest University Health Sciences
Winston-salem
Nebraska
South Lincoln Dermatology Clinic
Lincoln
Advanced Dermatology of the Midlands
Omaha
New Hampshire
Dartmouth-Hitchcock Medical Center
Lebanon
New Jersey
Windsor Dermatology
East Windsor
Linda Susan Marcus
Wyckoff
New York
Centurion Dermatology
Brooklyn
The University of Buffalo
Buffalo
Empire Dermatology
East Syracuse
Forest Hills Dermatology Group
Forest Hills
Greenwich Village Dermatology
New York
Ichan School of Medicine
New York
Advanced Allergy & Asthma, PLLC
Rockville Centre
Montefiore Medical Center
The Bronx
Ohio
Ohio State University
Columbus
Oklahoma
Allergy, Asthma & Clinical Research Center
Oklahoma City
Oregon
Oregon Health and Science University
Portland
Pennsylvania
Allergy and Clinical Immunology
Pittsburgh
South Carolina
The Medical University of South Carolina
Charleston
Texas
El Paso Dermatology Center
El Paso
North Texas Center for Clinical Research
Frisco
Asthma and Allergy Center
Lewisville
Center for Clinical Studies
Webster
Utah
Allergy Associates of Utah
Murray
University of Utah MidValley Dermatology
Murray
Virginia
Virginia Commonwealth University
Richmond
Washington
North Sound Dermatology
Mill Creek
Spokane Dermatology Clinic
Spokane
Wisconsin
Children's Hospital of Wisconsin
Milwaukee
West Virginia
Dermatology Center for Skin Health
Morgantown
Other Locations
Canada
Innovaderm Research, Inc.
Montreal
Skin Centre for Dermatology
Peterborough
York Dermatology Clinic and Research Centre
Richmond Hill
Saskatoon Dermatology Centre
Saskatoon
Germany
Dr. Bernhard Korge
Düren
UKSH- Institut für Entzündungsmedizin
Lübeck
Spain
Hospital Clinic de Barcelona
Barcelona
Hospital Universitario La Princesa
Madrid
Time Frame
Start Date: 2018-12-21
Completion Date: 2050-12
Participants
Target number of participants: 15000
Authors
Mehdi Rashighi, Amy Paller, Diana H Lee, Jamie Rhoads, Sunil S Dhawan, Brenda Simpson, Jeffrey Cizenski, Kenneth W Dawes, Mathew Davey, Kenneth Reed, Natasha Mesinkovska, Megha Tollefson, David Cypcar, Carl Thornblade, Robert Buka, Anil Nanda, Maria Hordinsky, Eric Simpson, Michael S Chapman, Jeffrey Weinberg, Rola Gharib, Barry Kuttner, Stephen Tyring, Benjamin Lockshin, Brian J Feinstein, Michael Cecchini, Lawrence F Eichenfield, Emma Guttman, Brenda LaTowsky, Heather Lehman, Heidi Zafra, James W Sublett, Gisela Torres-Bonilla, Sandra Johnson, Martha Tarpay, Diamant Thaci, Jonathan Silverberg, Jerry Bagel, Michael Sebastian, Drew Reese, Selina Gierer, Andrew J Peranteau, Tien Q Nguyen, Robert Bissonnette, Melinda Gooderham
Related Therapeutic Areas
Sponsors
Leads: Target PharmaSolutions, Inc.